Remove tag logistics
article thumbnail

Grand Rounds Biostatistics Series January 5, 2024: Methods for Handling Missing Data in Cluster Randomized Trials (Rui Wang, PhD; Moderator: Fan Li, PhD)

Rethinking Clinical Trials

One cautionary note when creating the propensity weights using logistic regression is that there’s issues with collapsibility. It’s important to note that these approaches are not wedded to logistic regression, as long as we have a sensible model for the missingness. The EM algorithm helps with that problem.

Trials 275
article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

There are substantial logistical burdens in preparing data for sharing, meaningful risks of reidentification, and concern for biased or misleading analyses, with little demonstrated demand for PCT data and relatively low social value from PCT data reuse. pctGR, @Collaboratory1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. Pearl O’Rourke, MD; David S. Wendler, PhD, MA; Miguel Vazquez, MD; P. Michael Ho, MD, PhD)

Rethinking Clinical Trials

There are consequences of notification, such as logistics and cost. Tags #pctGR, @Collaboratory1 The post Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. ICD-Pieces studied patients with chronic kidney disease (CKD), diabetes and hypertension. Pearl O’Rourke, MD; David S.

article thumbnail

Grand Rounds Ethics and Regulatory Series December 9, 2022: The Stepped Wedge Cluster Randomized Trial: Friend or Foe? (Monica Taljaard, PhD; David Magnus, PhD)

Rethinking Clinical Trials

Five methodological arguments for stepped wedge CRTs are to improve rigor, to facilitate recruitment, to reduce the required sample size, to simplify logistics, and to reduce bias; however, most methodological arguments in favor of stepped wedge trials have a counter argument. pctGR, @Collaboratory1.

Trials 130
article thumbnail

Grand Rounds February 24, 2023: S2302 Pragmatica-Lung: New Directions for Decreasing Burden and Increasing Inclusion in NCTN Clinical Trials (Konstantin Dragnev, MD; Karen Reckamp, MD, MS)

Rethinking Clinical Trials

They are both approved and used widely in lung cancer, and combining two existing agents is logistically and clinically simpler. . – What was the rationale for the choice of study treatments (i.e., verses other immunotherapeutic agents)? There is a strong mechanistic rationale.

article thumbnail

Sarepta’s Elevidys Reaches Finish Line as First Gene Therapy Approved for Duchenne Muscular Dystrophy

XTalks

million price tag of Elevidys, a one-time gene therapy. Ingram expects the launch to take a few months to pick up due to logistical and policy issues. It has taken Sarepta six years to develop Elevidys with several roadblocks in its journey, including two clinical holds due to safety concerns.

article thumbnail

How COVID-19 Impacted the Food Supply Chain For Better and for Worse

XTalks

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. Hoarding, which is on the demand side, and supply side issues with labor, factories and logistics. Having that transparency in data is critical and it’s what’s leading the inevitable tech takeover of logistics.”.